615 related articles for article (PubMed ID: 31691646)
21. Risk behaviours and viral infections among drug injecting migrants from the former Soviet Union in Germany: Results from the DRUCK-study.
Derks L; Gassowski M; Nielsen S; An der Heiden M; Bannert N; Bock CT; Bremer V; Kücherer C; Ross S; Wenz B; Marcus U; Zimmermann R;
Int J Drug Policy; 2018 Sep; 59():54-62. PubMed ID: 30005420
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and risk factors of HIV infection among people who inject drugs in Cambodia: findings from a national survey.
Mburu G; Chhoun P; Chann N; Tuot S; Mun P; Yi S
Subst Abuse Treat Prev Policy; 2019 Oct; 14(1):42. PubMed ID: 31623645
[TBL] [Abstract][Full Text] [Related]
23. Drug use stigma and its association with active hepatitis C virus infection and injection drug use behaviors among community-based people who inject drugs in India.
Patel EU; Solomon SS; Lucas GM; McFall AM; Tomori C; Srikrishnan AK; Kumar MS; Laeyendecker O; Celentano DD; Thomas DL; Quinn TC; Mehta SH
Int J Drug Policy; 2021 Oct; 96():103354. PubMed ID: 34247900
[TBL] [Abstract][Full Text] [Related]
24. Age-Related Differences in Past or Present Hepatitis C Virus Infection Among People Who Inject Drugs: National Human Immunodeficiency Virus Behavioral Surveillance, 8 US Cities, 2015.
Abara WE; Trujillo L; Broz D; Finlayson T; Teshale E; Paz-Bailey G; Glick S; Al-Tayyib AA; Robinson WT; Masiello-Schuette S; Sey EK; Anderson BJ; Poe J; Braunstein S
J Infect Dis; 2019 Jul; 220(3):377-385. PubMed ID: 30915477
[TBL] [Abstract][Full Text] [Related]
25. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.
Solomon SS; Mehta SH; Srikrishnan AK; Solomon S; McFall AM; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Lucas GM; Kumar MS; Sulkowski MS; Quinn TC
Lancet Infect Dis; 2015 Jan; 15(1):36-45. PubMed ID: 25486851
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C care continuum and associated barriers among people who inject drugs in Chennai, India.
Patel EU; Solomon SS; Mcfall AM; Srikrishnan AK; Pradeep A; Nandagopal P; Laeyendecker O; Tobian AAR; Thomas DL; Sulkowski MS; Kumar MS; Mehta SH
Int J Drug Policy; 2018 Jul; 57():51-60. PubMed ID: 29679811
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B and C Virus Infections Among Human Immunodeficiency Virus-Infected People Who Inject Drugs in Lahore, Pakistan.
Mansha S; Imran M; Shah AMUH; Jamal M; Ahmed F; Atif M; Saleem M; Safi SZ; Fatima Z; Bilal Waqar A
Viral Immunol; 2017 Jun; 30(5):366-370. PubMed ID: 28346804
[TBL] [Abstract][Full Text] [Related]
28. HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination.
Leyna GH; Makyao N; Mwijage A; Ramadhan A; Likindikoki S; Mizinduko M; Leshabari MT; Moen K; Mmbaga EJ
Harm Reduct J; 2019 Dec; 16(1):68. PubMed ID: 31829199
[TBL] [Abstract][Full Text] [Related]
29. Characteristics associated with HIV and hepatitis C seroprevalence among sexual and injecting partners of HIV positive persons who inject drugs in Nairobi and coastal Kenya.
Sambai BC; Kingston H; Monroe-Wise A; Mbogo L; Juma E; Ludwig-Barron N; Guthrie BL; Bukusi D; Chohan BH; Scott J; Bosire R; Dunbar M; Macharia P; Masyuko S; Sinkele W; Herbeck JT; Farquhar C
BMC Infect Dis; 2022 Jan; 22(1):73. PubMed ID: 35062890
[TBL] [Abstract][Full Text] [Related]
30. Underreported injection drug use and its potential contribution to reported increase in sexual transmission of HIV in Kazakhstan and Kyrgyzstan.
Deryabina AP; Patnaik P; El-Sadr WM
Harm Reduct J; 2019 Jan; 16(1):1. PubMed ID: 30611251
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C and HIV in injecting drug users in Armenia, Colombia.
Berbesi-Fernández D; Segura-Cardona Á; Montoya-Vélez L; Castaño-Perez GA
Adicciones; 2015 Dec; 27(4):246-52. PubMed ID: 26706807
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and correlates of HCV monoinfection and HIV and HCV coinfection among persons who inject drugs in Vietnam.
Zhang L; Celentano DD; Le Minh N; Latkin CA; Mehta SH; Frangakis C; Ha TV; Mo TT; Sripaipan T; Davis WW; Quan VM; Go VF
Eur J Gastroenterol Hepatol; 2015 May; 27(5):550-6. PubMed ID: 25769097
[TBL] [Abstract][Full Text] [Related]
33. Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012.
Kim NJ; Jin H; McFarland W; Raymond HF
Int J Drug Policy; 2015 Dec; 26(12):1238-43. PubMed ID: 26365768
[TBL] [Abstract][Full Text] [Related]
34. High burden of hepatitis C & HIV co-infection among people who inject drugs in Manipur, Northeast India.
Kermode M; Nuken A; Medhi GK; Akoijam BS; Sharma HU; Mahanta J
Indian J Med Res; 2016 Mar; 143(3):348-56. PubMed ID: 27241649
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and high risk behaviours associated with HCV testing among people who inject drugs: a systematic review and Meta-analysis.
Karimi SE; Bayani A; Higgs P; Bayat AH; Hemmat M; Ahounbar E; Armoon B; Fakhri Y
Subst Abuse Treat Prev Policy; 2020 Aug; 15(1):64. PubMed ID: 32831107
[TBL] [Abstract][Full Text] [Related]
36. High regional variability of HIV, HCV and injecting risks among people who inject drugs in Poland: comparing a cross-sectional bio-behavioural study with case-based surveillance.
Rosińska M; Sierosławski J; Wiessing L
BMC Infect Dis; 2015 Feb; 15():83. PubMed ID: 25879904
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis C virus prevalence, determinants, and cascade of care among people who inject drugs in Iran.
Khezri M; Mirzazadeh A; Shokoohi M; Sharafi H; Ghalekhani N; Tavakoli F; Mehmandoost S; Mousavian G; Imani M; Kakavand-Ghalehnoei R; Komasi A; Gouya MM; Haghdoost AA; McFarland W; Karamouzian M; Sharifi H
Drug Alcohol Depend; 2023 Feb; 243():109751. PubMed ID: 36621200
[TBL] [Abstract][Full Text] [Related]
38. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey.
Scheibe A; Young K; Moses L; Basson RL; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Manamela J; Puren AJ; Rebe K; Hausler H
Harm Reduct J; 2019 Apr; 16(1):28. PubMed ID: 30975139
[TBL] [Abstract][Full Text] [Related]
39. Re-emergence of HIV related to injecting drug use despite a comprehensive harm reduction environment: a cross-sectional analysis.
McAuley A; Palmateer NE; Goldberg DJ; Trayner KMA; Shepherd SJ; Gunson RN; Metcalfe R; Milosevic C; Taylor A; Munro A; Hutchinson SJ
Lancet HIV; 2019 May; 6(5):e315-e324. PubMed ID: 30981674
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of HIV and other infections and correlates of needle and syringe sharing among people who inject drugs in Podgorica, Montenegro: a respondent-driven sampling survey.
Lausevic D; Begic S; Mugosa B; Terzic N; Vratnica Z; Labovic I; Bozicevic I
Harm Reduct J; 2015 Feb; 12():2. PubMed ID: 25884194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
